How AI Is Aiming at the Bad Math of Drug Development

Robert Marcus
Nov 29, 2021

Related news

Sep 22
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Paige Receives First Ever FDA Approval for AI Product in Digital Pathology

Dec 21
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Experts predict growth in Pharma-AI use research

Dec 9
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Nordic VS Eir raises funds for LS investing

Nov 1
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Our Relationship with AI: Friend Or Foe? Summary of our Global Study

Nov 3
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

AWS Snatches Growth-Rate Momentum from Microsoft, Cites Machine Learning

Nov 9
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Accenture (ACN) Announces Strategic Investment in Geneyx

Oct 5
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Google’s DeepMind turns first profit as revenues soar

Mar 12
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Do Algorithms Make Better and Fairer Investments Than Angel Investors?

Dec 10
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Biotech investors cap off record year in fundraising

Feb 21
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Intelligence Artificielle : l'UM6P signe un partenariat avec la start-up ALPHA10X

Mar 2
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

ALPHA10X : de l’IA pour réduire le risque lié à l’investissement dans les sciences de la vie

Feb 21
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Morocco’s Mohammed VI Polytechnic University and ALPHA10X Sign Research and Development Partnership Agreement